AstraZeneca (AZN) has agreed to supply up to 400 million doses of the University of Oxford’s COVID-19 vaccine, AZD1222, to Europe’s Inclusive Vaccines Alliance (IVA), with deliveries starting by the end of 2020.Total manufacturing capacity for AZD1222 now stands at two billion doses, says AZN.Spearheaded by Germany, France, Italy and the Netherlands, the IVA says it aims to accelerate the supply of the vaccine and to make it available to other European countries that wish to participate in the initiative.At the same time, UK-based AstraZeneca continues to build several global supply chains, including for Europe. “The company is seeking to …read more
Source:: Yahoo Finance
